Chemotherapy News and Research

Latest Chemotherapy News and Research

Modern chemo more effective than second targeted hormone therapy against resistant prostate cancer

A modern chemotherapy drug is more effective for men with advanced prostate cancer than a second targeted hormone therapy in patients who have stopped responding to treatment, a major clinical trial shows.

30 Sep 2019

Breast, ovarian cancer drug more effective than targeted hormone therapy in some men with prostate cancer

A drug used for breast and ovarian cancer is more effective than modern targeted hormone treatments at slowing progression and improving survival in some men with advanced prostate cancer, phase III clinical trial findings reveal.

30 Sep 2019

Infectious disease experts explain how to stay healthy during the flu season

About 40 million people contracted the flu last year, with hundreds of thousands hospitalized and 35,400 to 61,000 deaths, including 134 children, according to the Centers for Disease Control and Prevention.

30 Sep 2019

Intensive new combination therapy for ovarian cancer shows promising results

Researchers have found that more intensive chemotherapy maintenance for ovarian cancer could be beneficial for patients. The results of the study were presented at the ESMO Congress 2019 in Barcelona, Spain last weekend on the 28th of September.

30 Sep 2019

Lung cancer may soon be picked up by a blood test

A study presented at the ESMO Congress 2019 has revealed that a blood test may soon be able to pick up circulating tumor DNA to help avoid invasive tissue biopsies in lung cancer patients.

30 Sep 2019

Novel immunotherapy combination could provide fresh hope for patients with cervical cancer

With an estimated 570,000 cases and 311,000 deaths in 2018 worldwide, cervical cancer currently ranks as the fourth most frequently diagnosed cancer and the fourth leading cause of cancer death in women.

30 Sep 2019

Novel therapeutic approach improves survival in patients newly diagnosed with advanced ovarian cancer

An international study demonstrates that administering niraparib after conventional chemotherapy treatment in patients newly diagnosed with advanced ovarian cancer, improves their progression-free survival, and reduces their risk of relapse or death from this disease.

28 Sep 2019

Combination of two immunotherapy drugs stops or reverses progression of advanced melanoma

A combination of two immunotherapy drugs, ipilimumab and nivolumab, has stopped or reversed the progression of advanced melanoma for five years or more in one in two patients, according to a study led by The Royal Marsden NHS Foundation Trust.

28 Sep 2019

PARP inhibitor combined with chemotherapy increases survival for newly diagnosed ovarian cancer patients

Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free survival for patients with newly diagnosed, metastatic high-grade serous ovarian cancer, according to the results of the VELIA trial.

28 Sep 2019

Higher levels of genetic mutations linked to improved outcomes in lung cancer patients

According to new findings by Yale Cancer Center scientists, higher levels of genetic mutations in a tumor biopsy are linked to improved clinical outcomes in patients using pembrolizumab (Keytruda) to treat non-small cell lung cancer (NSCLC).

27 Sep 2019

Stem cells lost in freezer malfunction: hospital apologizes and offers full support

Los Angeles hospital has apologized and offered full support after stem cells perish in fridge malfunction.

27 Sep 2019

Children's of Alabama using cold sore virus to fight pediatric brain cancer

Children's of Alabama is home to one of the most exciting studies underway in pediatric cancer: evaluating the use of a cold sore virus to treat children with progressive malignant brain tumors.

26 Sep 2019

Partial, whole breast radiation after lumpectomy yield similar cosmetic outcomes

Whole breast radiation and partial breast radiation following a lumpectomy yield similar cosmetic outcomes for women diagnosed with early stages of cancer who wish to preserve their breasts.

26 Sep 2019

AI accurately predicts radiation therapy side effects for patients with head and neck cancers

For the first time, a sophisticated computer model has been shown to accurately predict two of the most challenging side effects associated with radiation therapy for head and neck cancer.

26 Sep 2019

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates the immune system in some patients with metastatic non-small-cell lung cancer, increasing progression-free survival.

26 Sep 2019

Late-breaking TAILORx data to be presented at ESMO Congress 2019

New data from TAILORx, the federally funded, phase three clinical trial, will be presented as late-breaking information at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain.

26 Sep 2019

Only half of patients with sinus, throat, or ear infections receive first-line antibiotics

Investigators have now shown that only half of patients presenting with sinus, throat, or ear infections at different treatment centers received the recommended first-line antibiotics, well below the industry standard of 80 percent.

25 Sep 2019

Nanotechnology enhances delivery of chemotherapy drugs

Michigan State University scientists have invented a new way to monitor chemotherapy concentrations, which is more effective in keeping patients' treatments within the crucial therapeutic window.

25 Sep 2019

New compound could take on lethal fungal, bacterial infections in immunocompromised people

Immunodeficiency is the condition where the capability of the immune system to fight against diseases has been compromised.

25 Sep 2019

UCLA researchers identify new drug delivery pathway to stop tumor growth

Researchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new drug delivery pathway that may help stop tumor growth and keep cancer from coming back in mice.

25 Sep 2019

Chemotherapy News and Research

Latest Chemotherapy News and Research

Modern chemo more effective than second targeted hormone therapy against resistant prostate cancer

Breast, ovarian cancer drug more effective than targeted hormone therapy in some men with prostate cancer

Infectious disease experts explain how to stay healthy during the flu season

Intensive new combination therapy for ovarian cancer shows promising results

Lung cancer may soon be picked up by a blood test

Novel immunotherapy combination could provide fresh hope for patients with cervical cancer

Novel therapeutic approach improves survival in patients newly diagnosed with advanced ovarian cancer

Combination of two immunotherapy drugs stops or reverses progression of advanced melanoma

PARP inhibitor combined with chemotherapy increases survival for newly diagnosed ovarian cancer patients

Higher levels of genetic mutations linked to improved outcomes in lung cancer patients

Stem cells lost in freezer malfunction: hospital apologizes and offers full support

Children's of Alabama using cold sore virus to fight pediatric brain cancer

Partial, whole breast radiation after lumpectomy yield similar cosmetic outcomes

AI accurately predicts radiation therapy side effects for patients with head and neck cancers

Adding radiation after immunotherapy increases PFS for some patients with metastatic NSCLC

Late-breaking TAILORx data to be presented at ESMO Congress 2019

Only half of patients with sinus, throat, or ear infections receive first-line antibiotics

Nanotechnology enhances delivery of chemotherapy drugs

New compound could take on lethal fungal, bacterial infections in immunocompromised people

UCLA researchers identify new drug delivery pathway to stop tumor growth

Cancer Research - Second Edition eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in